BC	Breast cancer
BP	Black phosphorus
DFO	Desferrioxamine
DOX	Doxorubicin
EGFR	Epidermal growth factor receptor
EPR	Enhanced permeability and retention
EPS	Epalrestat
ER	Estrogen receptor
FDA	Food and Drug Administration
gpNMB	Glycoprotein non-metastatic B
HA	Hyaluronic acid
HER2	Human epidermal growth factor receptor 2
ICAM1	Intercellular adhesion molecule-1
IHC	Immunohistochemistry
LET	Linear energy transfer
mAb	Monoclonal antibody
MELK	Maternal embryonic leucine zipper kinase
MMAE	Monomethyl auristatin E
MMP	Multifunctional molecular probe
MR	Magnetic resonance
MRI	Magnetic resonance imaging
Nectin-4	Nectin cell adhesion molecule 4
NIR	Near-infrared
NIRF	Near-infrared fluorescence
NPs	Nanoparticles
PD-1	Programmed cell death protein-1
PD-L1	Programmed death-ligand 1
PDA	Polydopamine
PDT	Photodynamic therapy
PEG	Polyethylene glycol
PET	Positron emission tomography
PFH	Perfluorohexane
PLGA	Poly (lactic-co-glycolic acid)
PpIX	Protoporphyrin IX
PR	Progesterone receptor
PTT	Photothermal therapy
PTX	Paclitaxel
RES	Reticuloendothelial system
ROS	Reactive oxygen species
SPECT	Single photon emission computed tomography
TNBC	Triple-negative breast cancer
TPZ	Tirapazamine
UCL	Upconversion luminescence
UCNPs	Upconversion nanoparticles
uPA	Urokinase plasminogen activator
uPAR	Urokinase plasminogen activator receptor